← State exam

108. Thromboembolic complications in surgery

High yield

Deep vein thrombosis and pulmonary embolism after surgery; assess every patient, prevent it, and treat it fast.

Exam Prep · State examSurgery · General surgery

1. Definition

  • Venous thromboembolism (VTE) → deep vein thrombosis (DVT) and pulmonary embolism (PE), two stages of one disease
  • DVT → thrombus in the deep veins, usually of the leg or pelvis
    • Distal → calf veins below the popliteal vein
    • Proximal → popliteal, femoral, iliac veins (higher risk of PE)
  • PE → blockage of the pulmonary arteries by thrombus, usually from the leg or pelvic veins
  • Superficial thrombophlebitis → thrombosis and inflammation of a superficial vein (great or small saphenous)
  • Other emboli in surgery → fat embolism (long-bone fractures), air embolism (central lines, neurosurgery, laparoscopy), amniotic fluid, tumour, arterial (cardiac) emboli
  • This question covers mainly postoperative VTE

2. Epidemiology

  • VTE affects about 1–2 per 1000 people a year; risk rises steeply with age (1 in 100 over 80 years each year)
  • Without prophylaxis → DVT in about 20–30% of general surgical patients and 40–60% after hip or knee replacement
  • Hospital-acquired VTE causes about two-thirds of all VTE; much of it is preventable
  • Untreated proximal DVT → about 50% embolise
  • PE → mortality about 5–25%; the highest risk of fatal postoperative PE is 3–7 days after surgery
  • About 10% of symptomatic PEs kill within 1 hour
  • Over half of postoperative VTE occurs after discharge; risk lasts up to 3 months

3. Aetiology and risk factors

Virchow's triad

  • Stasis → immobility, anaesthesia and paralysis, long operations, heart failure, pneumoperitoneum
  • Endothelial injury → surgery, trauma, central lines, previous DVT
  • Hypercoagulability → surgery itself, cancer, sepsis, pregnancy, oestrogen, thrombophilia

Patient factors

  • Age over 60, obesity (BMI over 30)
  • Active cancer or cancer treatment
  • Previous VTE, family history in a first-degree relative
  • Thrombophilia → factor V Leiden (most common, about 5% of Europeans), prothrombin G20210A, protein C, protein S or antithrombin deficiency, antiphospholipid syndrome
  • Oestrogen → combined oral contraceptive, HRT; pregnancy and up to 6 weeks after birth
  • Varicose veins with phlebitis, dehydration, heart or respiratory failure, inflammatory bowel disease, nephrotic syndrome, myeloproliferative disease

Surgical factors

  • Major abdominal and pelvic surgery, especially for cancer
  • Hip and knee replacement, hip fracture, spinal cord injury, major trauma
  • Operation over 90 minutes (or over 60 minutes in the pelvis or lower limb)
  • Emergency surgery with an inflammatory or intra-abdominal condition
  • Reduced mobility for 3 days or more, plaster cast

4. Pathogenesis

  • Most DVTs start in the soleal sinuses and valve pockets of the calf veins, often during the operation
  • About half of intraoperative calf thrombi lyse within 72 hours; about 20% extend proximally
  • Red thrombus (red cells in fibrin) grows into a free-floating tail → breaks off → embolus
  • PE → emboli lodge in the pulmonary arteries:
    • Increased pulmonary vascular resistance → right ventricular strain and dilatation
    • Ventricular septum bows into the left ventricle → low cardiac output, hypotension
    • Dead space (ventilation without perfusion) and shunting → hypoxaemia
    • Small peripheral emboli → pulmonary infarction (pleuritic pain, haemoptysis)
  • Long-term → valve damage → post-thrombotic syndrome; unresolved emboli → chronic thromboembolic pulmonary hypertension (CTEPH)

5. Classification

DVT

  • Distal (calf) and proximal (popliteal and above)
  • Iliofemoral DVT → whole leg swollen
  • Phlegmasia alba dolens → white, swollen, painful leg (iliofemoral DVT)
  • Phlegmasia caerulea dolens → blue, massively swollen leg with arterial compromise; may progress to venous gangrene

PE (European Society of Cardiology)

  • High risk (massive) → shock or hypotension (systolic under 90 mmHg)
  • Intermediate risk (submassive) → stable but right ventricular dysfunction on echo or CT, raised troponin
  • Low risk → stable, no RV strain (PESI class I–II or sPESI 0)

By timing

  • Provoked (transient risk factor such as surgery) and unprovoked
Grid of DVT and PE features and risk groups
Diagram: features, key tests and treatment of DVT and of each PE risk group

6. Clinical picture

DVT

  • Often silent; the first sign may be PE
  • Pain and tenderness along the deep veins of the calf or thigh
  • Unilateral swelling (calf over 3 cm larger, measured 10 cm below the tibial tuberosity), pitting oedema
  • Warmth, redness, dilated superficial collateral veins, low-grade fever
  • Homans' sign (calf pain on dorsiflexion) is unreliable and not recommended

PE

  • Sudden breathlessness (most common), tachypnoea, tachycardia
  • Pleuritic chest pain, cough, haemoptysis (infarction)
  • Collapse, syncope, hypotension, raised JVP, cyanosis → massive PE
  • Low-grade fever, signs of DVT
  • Unexplained hypoxia, AF or tachycardia in a postoperative patient → think of PE
  • Cardiac arrest with pulseless electrical activity

7. Diagnosis

Suspected DVT

  • Two-level Wells score for DVT → DVT likely (2 or more points) or unlikely (1 or fewer)
  • DVT likely → proximal leg vein ultrasound within 4 hours; if negative, D-dimer, and repeat ultrasound in 6–8 days if D-dimer is positive
  • DVT unlikely → D-dimer; if negative, DVT is excluded; if positive, ultrasound
  • D-dimer is sensitive but not specific; raised after surgery, in cancer, infection, pregnancy and old age, so it is of little use in the first weeks after surgery
  • Duplex ultrasound (compression) → test of choice (sensitivity 94–99% for proximal DVT)
  • CT or MR venography → iliac and caval thrombosis

Suspected PE

  • Two-level Wells score for PE → PE likely (over 4 points) or unlikely (4 or fewer); PERC rule to avoid tests in very low-risk patients
  • PE likely → CT pulmonary angiography (CTPA) at once; if delayed, start anticoagulation
  • PE unlikely → D-dimer; if positive, CTPA
  • V/Q scan → if contrast allergy, renal failure, or pregnancy with normal chest X-ray
  • Bedside echo in the unstable patient → right ventricular dilatation, McConnell's sign
  • Supporting tests:
    • ECG → sinus tachycardia (most common), right heart strain, new RBBB, S1Q3T3 (uncommon)
    • Chest X-ray → usually normal; excludes other causes
    • ABG → hypoxaemia, hypocapnia
    • Troponin and BNP → right ventricular strain, risk grading
  • Pregnancy → leg ultrasound first, then V/Q or CTPA
  • Unprovoked VTE → history, examination and basic tests for cancer; thrombophilia testing only in selected patients and not while on anticoagulants
Flowchart for suspected postoperative DVT or PE
Diagram: from Wells score to D-dimer, ultrasound or CTPA, then to treatment

8. Differential diagnosis

  • Of DVT → cellulitis, ruptured Baker's cyst, muscle tear or haematoma, superficial thrombophlebitis, lymphoedema, heart or kidney failure oedema, compartment syndrome, sarcoma
  • Of PE → myocardial infarction, pneumonia, pneumothorax, aortic dissection, pericarditis, pulmonary oedema, atelectasis, sepsis
  • Of postoperative breathlessness → atelectasis, pneumonia, fluid overload, anastomotic leak with sepsis

9. Treatment

Conservative

  • Prevention (thromboprophylaxis):
    • Assess every patient for VTE and bleeding risk on admission and again after 24 hours (NICE NG89 risk tool)
    • Early mobilisation, leg exercises, good hydration
    • Stop combined oral contraceptives or HRT 4 weeks before major elective surgery
    • Mechanical → intermittent pneumatic compression (IPC) during and after surgery; anti-embolism stockings if no contraindication
      • Contraindications to stockings → peripheral arterial disease, neuropathy, skin grafts, severe leg oedema
      • The GAPS trial (2020) found no extra benefit of stockings on top of LMWH in elective surgery
    • Pharmacological → low-molecular-weight heparin (LMWH) such as enoxaparin 40 mg or dalteparin 5000 units once daily, starting 6–12 hours after surgery
      • Unfractionated heparin in severe renal failure
      • Fondaparinux as an alternative
    • Extended prophylaxis for 28 days → major abdominal or pelvic cancer surgery
    • Orthopaedics → after hip replacement 28–35 days (LMWH, DOAC or aspirin in selected cases); after knee replacement 14 days
    • Neuraxial anaesthesia → time LMWH doses around spinal or epidural catheter insertion and removal
  • Treatment of DVT and PE:
    • Start anticoagulation at once when VTE is confirmed, or suspected and tests are delayed
    • First choice → a direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban (no injection or monitoring needed)
    • Alternatives → LMWH for at least 5 days followed by dabigatran or edoxaban; or LMWH with warfarin until INR is 2–3 for 2 days in a row
    • LMWH (or a DOAC) in cancer-associated VTE; LMWH in pregnancy (warfarin is teratogenic, DOACs are not used)
    • Unfractionated heparin infusion → severe renal failure, high bleeding risk, possible thrombolysis or surgery (short half-life, reversible with protamine)
    • Duration:
      • 3 months after a provoked VTE (surgery is a strong transient risk factor)
      • At least 3–6 months, often long-term, after unprovoked VTE if bleeding risk is low
      • As long as cancer is active
    • Isolated calf DVT → anticoagulate for 3 months, or repeat ultrasound in 1 week if bleeding risk is high
    • Early mobilisation is safe once anticoagulated; compression stockings do not prevent post-thrombotic syndrome
    • Superficial thrombophlebitis over 5 cm → fondaparinux 2.5 mg for 45 days; ultrasound to exclude DVT if near the saphenofemoral junction
  • Heparin-induced thrombocytopenia (HIT) → platelets fall by over 50% at days 5–10 with new thrombosis → stop all heparin and give a non-heparin anticoagulant (argatroban, fondaparinux, DOAC)
  • Massive PE → oxygen, careful fluids, vasopressors, unfractionated heparin and systemic thrombolysis (alteplase) unless contraindicated

Surgical

  • Catheter-directed thrombolysis or mechanical thrombectomy → massive PE with contraindication to or failure of thrombolysis; extensive iliofemoral DVT in young fit patients (less post-thrombotic syndrome); phlegmasia caerulea dolens
  • Surgical pulmonary embolectomy (cardiopulmonary bypass) → massive PE when thrombolysis fails or is contraindicated
  • Inferior vena cava (IVC) filter → proximal DVT or PE with a contraindication to anticoagulation (for example, recent major surgery or active bleeding), or recurrent PE despite proper anticoagulation
    • Use retrievable filters and remove them when anticoagulation can start
    • Filters do not treat the DVT and raise the risk of later DVT
  • Venous thrombectomy → phlegmasia caerulea dolens with threatened limb when thrombolysis is not possible
  • Pulmonary endarterectomy → selected patients with CTEPH

10. Complications

Of VTE

  • Fatal PE
  • Recurrent VTE → 7–13% in the first year after stopping treatment, higher after unprovoked VTE
  • Post-thrombotic syndrome (20–50% after DVT) → chronic swelling, pain, heaviness, skin changes, venous ulcers
  • CTEPH (about 2–4% after PE) → breathlessness, right heart failure
  • Venous gangrene in phlegmasia caerulea dolens
  • Paradoxical embolism (stroke) through a patent foramen ovale

Of treatment

  • Major bleeding → about 1–3% a year on anticoagulants; higher with warfarin and in the elderly
  • Reversal agents → vitamin K and prothrombin complex concentrate (warfarin), protamine (heparin), idarucizumab (dabigatran), andexanet alfa or prothrombin complex concentrate (factor Xa inhibitors)
  • HIT, osteoporosis with long-term heparin, wound haematoma
  • IVC filter thrombosis, migration, fracture

Prognosis

  • Most patients with treated DVT or PE recover; PE with shock still carries over 25% mortality

Mind map Pinch or scroll to zoom · drag to move

Show as a list

Thromboembolic complications

  • Virchow's triad
    • Stasis
    • Vessel injury
    • Hypercoagulability
  • Risk factors
    • Age, cancer, previous VTE
    • Major pelvic surgery
    • Hip, knee replacement
  • Prevention
    • Risk assessment
    • Mobilise early
    • IPC, stockings
    • LMWH, 28 days cancer
  • DVT
    • Swelling, pain
    • Wells, D-dimer
    • Duplex ultrasound
  • PE
    • Dyspnoea, tachycardia
    • CTPA
    • Massive: thrombolysis
  • Treatment
    • DOAC first
    • LMWH in cancer, pregnancy
    • 3 months if provoked
    • IVC filter if no anticoagulation

More in State exam